Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Intellia Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NTLA
Nasdaq
8731
https://www.intelliatx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Intellia Therapeutics Inc
2 Stocks Down 30% to Buy Right Now
- Apr 14th, 2024 9:55 am
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
- Apr 12th, 2024 8:50 am
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
- Apr 9th, 2024 8:50 am
Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this week, taking three-year losses to 65%
- Apr 6th, 2024 12:47 pm
Better Cathie Wood Stock: Moderna vs. Intellia
- Mar 28th, 2024 9:55 am
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
- Mar 21st, 2024 9:29 pm
3 Stocks That Could Be the Next Big Thing in Gene Editing
- Mar 21st, 2024 8:19 pm
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
- Mar 19th, 2024 5:06 pm
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
- Mar 18th, 2024 11:30 am
Is Intellia Therapeutics Stock a Buy Now?
- Mar 9th, 2024 2:45 pm
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
- Mar 6th, 2024 3:35 pm
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
- Feb 29th, 2024 10:50 am
Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for Investors
- Feb 28th, 2024 2:30 pm
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
- Feb 27th, 2024 4:55 pm
Intellia Therapeutics, Inc. (NTLA) Just Overtook the 20-Day Moving Average
- Feb 27th, 2024 2:35 pm
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
- Feb 25th, 2024 12:54 pm
Intellia Therapeutics Full Year 2023 Earnings: Revenues Disappoint
- Feb 24th, 2024 12:11 pm
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 5:22 pm
Intellia (NTLA) Beats on Q4 Earnings, Provides Pipeline Update
- Feb 23rd, 2024 4:12 pm
Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock Really Move This High?
- Feb 23rd, 2024 2:55 pm
Scroll